Stanford Study Cuts Suicidal Ideation in 50 Depressed Adults With Ketamine-Buprenorphine Combo
Updated
Updated · The Washington Post · May 19
Stanford Study Cuts Suicidal Ideation in 50 Depressed Adults With Ketamine-Buprenorphine Combo
3 articles · Updated · The Washington Post · May 19
A randomized trial in 50 adults with major depressive disorder and active suicidal behavior found that one ketamine infusion followed by four weeks of ultra-low-dose buprenorphine sustained bigger reductions in suicidal thoughts than placebo.
All patients received ketamine first, then were randomized two days later to buprenorphine or placebo and assessed weekly; researchers said the regimen could extend ketamine’s typically short-lived anti-suicidal effect.
Depressive symptoms improved in both groups, but the study found no statistically significant difference on depression itself, suggesting the added benefit was specific to suicidal ideation rather than overall mood.
Researchers reported some rebound in suicidal thoughts and depression after treatment stopped, though patients remained better than baseline and showed no signs of withdrawal symptoms.
Outside experts called the findings promising but preliminary, noting the endpoints were questionnaire-based and urging larger, longer studies before broad clinical adoption.
A new ketamine cocktail offers rapid suicide relief, but are we overlooking its potential long-term dangers?
Why does this new drug combo stop suicidal thoughts but not the depression that causes them?
If a pill can treat suicidal thoughts separately from depression, should we rethink what mental illness is?
Breakthrough Stanford Research: Dual Drug Therapy Offers Rapid and Lasting Relief from Suicidal Ideation
Overview
Stanford University School of Medicine announced a groundbreaking study on May 19, 2026, led by Professors Alan F. Schatzberg and Jason M. Tucciarone. The research introduces a novel combination therapy that is redefining the approach to treating suicidal ideation and offers new hope for individuals struggling with severe mental distress. This innovative treatment strategy emerged from earlier research highlighting a strong connection between physical pain, psychological pain, and suicidality, and was inspired by a 2016 Israeli study. The new therapy has shown remarkable efficacy in reducing suicidal thoughts, marking a significant advancement in mental health care.